首页 > 最新文献

THERAPEUTISCHE UMSCHAU最新文献

英文 中文
[Cutaneous reactions to drugs]. [对药物的皮肤反应]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 DOI: 10.23785/TU.2025.04.003
Ines Lederbogen, Barbara Meier-Schiesser

Introduction: Adverse drug reactions (ADRs) are a major global health problem with high morbidity and mortality rates. They are divided into two main types: the more common type A reactions, which are dose-dependent and usually predictable, and the rarer type B reactions, which occur independently of the dose and require an individual predisposition on the part of the patient and often pose a particular challenge in everyday clinical practice. The majority of cutaneous adverse drug reactions (ADRs) are uncomplicated. The most common are maculopapular exanthema, which typically represent a type IV hypersensitivity reaction. Serious cutaneous ADRs, on the other hand, are rare but can be potentially life-threatening. Skin changes associated with immune checkpoint inhibitors and other immunotherapies represent a separate entity within cutaneous drug reactions. Immune-related adverse events (irAE) are common in immunotherapy and are considered in many cases to be a correlate of a positive therapeutic response.

药物不良反应(adr)是一个主要的全球性健康问题,发病率和死亡率都很高。它们主要分为两种类型:更常见的A型反应,这是剂量依赖性的,通常是可预测的;以及更罕见的B型反应,这与剂量无关,需要患者的个人易感性,并且在日常临床实践中经常构成特别的挑战。大多数皮肤药物不良反应(adr)并不复杂。最常见的是黄斑丘疹,这是典型的IV型过敏反应。另一方面,严重的皮肤不良反应很少见,但可能危及生命。与免疫检查点抑制剂和其他免疫疗法相关的皮肤变化在皮肤药物反应中是一个单独的实体。免疫相关不良事件(irAE)在免疫治疗中很常见,在许多情况下被认为是与阳性治疗反应相关的。
{"title":"[Cutaneous reactions to drugs].","authors":"Ines Lederbogen, Barbara Meier-Schiesser","doi":"10.23785/TU.2025.04.003","DOIUrl":"https://doi.org/10.23785/TU.2025.04.003","url":null,"abstract":"<p><strong>Introduction: </strong>Adverse drug reactions (ADRs) are a major global health problem with high morbidity and mortality rates. They are divided into two main types: the more common type A reactions, which are dose-dependent and usually predictable, and the rarer type B reactions, which occur independently of the dose and require an individual predisposition on the part of the patient and often pose a particular challenge in everyday clinical practice. The majority of cutaneous adverse drug reactions (ADRs) are uncomplicated. The most common are maculopapular exanthema, which typically represent a type IV hypersensitivity reaction. Serious cutaneous ADRs, on the other hand, are rare but can be potentially life-threatening. Skin changes associated with immune checkpoint inhibitors and other immunotherapies represent a separate entity within cutaneous drug reactions. Immune-related adverse events (irAE) are common in immunotherapy and are considered in many cases to be a correlate of a positive therapeutic response.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 4","pages":"111-116"},"PeriodicalIF":0.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145201560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tattoo ink between beauty and risk: regulation in Switzerland, the EU and the USA]. [纹身墨水在美丽与风险之间:瑞士、欧盟和美国的监管]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 DOI: 10.23785/TU.2025.04.009
Thomas D Szucs

Introduction: The growing popularity of tattoos highlights the importance of careful regulation of tattoo inks to minimise health risks. In Switzerland, tattoo inks are subject to strict legal requirements based on food legislation, which are designed to ensure that they are sterile and harmless. The European Union has significantly tightened restrictions on substances in tattoo inks through Regulation (EU) 2020/2081 in order to increase safety. In contrast, the USA regulate tattoo inks under the supervision of the Food and Drug Administration (FDA), but do not have specific pre-market controls for tattoo ink products. This comparison highlights different regulatory approaches in Switzerland, the EU and the USA and underlines the need for more harmonised global regulation to protect consumer health.

导读:纹身的日益流行凸显了仔细管理纹身墨水以尽量减少健康风险的重要性。在瑞士,纹身油墨受到食品法规严格的法律要求,以确保它们是无菌和无害的。欧盟通过法规(EU) 2020/2081大幅收紧了对纹身油墨中物质的限制,以提高安全性。相比之下,美国在食品和药物管理局(FDA)的监督下对纹身油墨进行监管,但对纹身油墨产品没有具体的上市前控制。这一比较突出了瑞士、欧盟和美国不同的监管方法,并强调需要更加协调的全球监管来保护消费者健康。
{"title":"[Tattoo ink between beauty and risk: regulation in Switzerland, the EU and the USA].","authors":"Thomas D Szucs","doi":"10.23785/TU.2025.04.009","DOIUrl":"10.23785/TU.2025.04.009","url":null,"abstract":"<p><strong>Introduction: </strong>The growing popularity of tattoos highlights the importance of careful regulation of tattoo inks to minimise health risks. In Switzerland, tattoo inks are subject to strict legal requirements based on food legislation, which are designed to ensure that they are sterile and harmless. The European Union has significantly tightened restrictions on substances in tattoo inks through Regulation (EU) 2020/2081 in order to increase safety. In contrast, the USA regulate tattoo inks under the supervision of the Food and Drug Administration (FDA), but do not have specific pre-market controls for tattoo ink products. This comparison highlights different regulatory approaches in Switzerland, the EU and the USA and underlines the need for more harmonised global regulation to protect consumer health.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 4","pages":"138-140"},"PeriodicalIF":0.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145201548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Secondary Headaches]. (二次头痛)。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.006
Laura Weichsel, Christoph Schankin

Introduction: In clinical practice, correctly diagnosing headaches can be challenging due to the many differential diagnoses. It is particularly important to differentiate between the more common primary headache types, where the headache itself is the main condition, and secondary headaches, which may have potentially lifethreatening causes. The diagnostic approach initially focuses on identifying secondary headaches.

导读:在临床实践中,由于许多鉴别诊断,正确诊断头痛是具有挑战性的。特别重要的是要区分更常见的原发性头痛类型,其中头痛本身是主要症状,而继发性头痛可能有潜在的危及生命的原因。诊断方法最初侧重于识别继发性头痛。
{"title":"[Secondary Headaches].","authors":"Laura Weichsel, Christoph Schankin","doi":"10.23785/TU.2025.03.006","DOIUrl":"https://doi.org/10.23785/TU.2025.03.006","url":null,"abstract":"<p><strong>Introduction: </strong>In clinical practice, correctly diagnosing headaches can be challenging due to the many differential diagnoses. It is particularly important to differentiate between the more common primary headache types, where the headache itself is the main condition, and secondary headaches, which may have potentially lifethreatening causes. The diagnostic approach initially focuses on identifying secondary headaches.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"94-99"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Polyneuropathies - a practical overview]. [多神经病变-实用概述]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.004
Marisa Blanquet, Andrea M Humm

Introduction: Polyneuropathies are common, can have very different clinical presentations and numerous causes. This article is intended to provide a practice-oriented overview of possible symptoms, the most important causes and a targeted, step-by-step diagnostic approach. Based on red flags, patients should be identified who urgently require a timely specialist assessment. The most important treatment approaches should be briefly explained.

简介:多神经病变是常见的,可以有非常不同的临床表现和许多原因。本文旨在以实践为导向,概述可能的症状、最重要的原因和有针对性的逐步诊断方法。根据危险信号,应该确定哪些患者迫切需要及时的专家评估。应简要说明最重要的治疗方法。
{"title":"[Polyneuropathies - a practical overview].","authors":"Marisa Blanquet, Andrea M Humm","doi":"10.23785/TU.2025.03.004","DOIUrl":"https://doi.org/10.23785/TU.2025.03.004","url":null,"abstract":"<p><strong>Introduction: </strong>Polyneuropathies are common, can have very different clinical presentations and numerous causes. This article is intended to provide a practice-oriented overview of possible symptoms, the most important causes and a targeted, step-by-step diagnostic approach. Based on red flags, patients should be identified who urgently require a timely specialist assessment. The most important treatment approaches should be briefly explained.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"82-87"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Leading neurological symptoms of stroke]. [中风的主要神经症状]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.007
Sebastian Kaufmann, Hakan Sarikaya, Moritz Kielkopf

Introduction: Stroke is a common, potentially life-threatening event that presents both acute and long-term challenges for patients and the healthcare system. The importance of educating patients about key symptoms, rapid diagnosis, and timely therapy is often underestimated. In addition to prevention through the optimal management of risk factors such as high blood pressure and diabetes, early detection of stroke symptoms is crucial. Modern and effective therapies such as thrombolysis and endovascular procedures can significantly improve outcomes if initiated promptly. Familiarity with stroke symptoms is essential for recognizing and differentiating so-called stroke mimics and stroke chameleons. In patients showing corresponding symptoms, immediate referral to a hospital is imperative. The 4-S acronym (Sehstörung, Sprachstörung, Schwäche, schnell handeln - visual disturbance, speech disturbance, weakness, act fast) serves as an easily understandable mnemonic for patients. If stroke is suspected, the emergency services (144) should be contacted immediately, as every minute counts ("Time is Brain"). Given that strokes can also present with atypical symptoms, rapid imaging is indispensable in uncertain cases to rule out misdiagnosis. In this context, general practitioners play a crucial role in early detection and timely referral, which again significantly improves the quality of care.

脑卒中是一种常见的、潜在的危及生命的事件,对患者和医疗保健系统提出了急性和长期的挑战。对患者进行关键症状教育、快速诊断和及时治疗的重要性往往被低估。除了通过对高血压和糖尿病等危险因素的最佳管理进行预防外,早期发现中风症状也至关重要。现代和有效的治疗方法,如溶栓和血管内手术可以显著改善结果,如果及时启动。熟悉中风症状对于识别和区分所谓的中风模仿者和中风变色龙至关重要。出现相应症状的患者,必须立即转诊至医院。4-S首字母缩略词(Sehstörung, Sprachstörung, Schwäche, schnell handeln -视觉障碍,语言障碍,虚弱,行动迅速)为患者提供了易于理解的助记符。如果怀疑中风,应立即联系急救中心(144),因为分秒必争(“时间就是大脑”)。鉴于中风也可能表现出非典型症状,在不确定的病例中,快速成像是必不可少的,以排除误诊。在这种情况下,全科医生在早期发现和及时转诊方面发挥着至关重要的作用,这再次显著提高了护理质量。
{"title":"[Leading neurological symptoms of stroke].","authors":"Sebastian Kaufmann, Hakan Sarikaya, Moritz Kielkopf","doi":"10.23785/TU.2025.03.007","DOIUrl":"https://doi.org/10.23785/TU.2025.03.007","url":null,"abstract":"<p><strong>Introduction: </strong>Stroke is a common, potentially life-threatening event that presents both acute and long-term challenges for patients and the healthcare system. The importance of educating patients about key symptoms, rapid diagnosis, and timely therapy is often underestimated. In addition to prevention through the optimal management of risk factors such as high blood pressure and diabetes, early detection of stroke symptoms is crucial. Modern and effective therapies such as thrombolysis and endovascular procedures can significantly improve outcomes if initiated promptly. Familiarity with stroke symptoms is essential for recognizing and differentiating so-called stroke mimics and stroke chameleons. In patients showing corresponding symptoms, immediate referral to a hospital is imperative. The 4-S acronym (Sehstörung, Sprachstörung, Schwäche, schnell handeln - visual disturbance, speech disturbance, weakness, act fast) serves as an easily understandable mnemonic for patients. If stroke is suspected, the emergency services (144) should be contacted immediately, as every minute counts (\"Time is Brain\"). Given that strokes can also present with atypical symptoms, rapid imaging is indispensable in uncertain cases to rule out misdiagnosis. In this context, general practitioners play a crucial role in early detection and timely referral, which again significantly improves the quality of care.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"100-104"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acute and episodic dizziness - diagnosis and treatment]. 急性和发作性头晕-诊断和治疗。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.005
Alexander A Tarnutzer

Introduction: Dizziness is one of the most common, yet diagnostically challenging cardinal symptoms with a wide range of causes. It accounts for 2-8 % of all consultations in both the emergency room and in general practice. The extremely broad differential diagnosis, which covers numerous medical specialties, the often transient nature of the symptoms, and the difficulty for patients to put the experienced symptoms into words, often make the evaluation of dizziness challenging. A structured history and targeted clinical examination - particularly with a focus on duration, triggers and oculomotor signs (HINTS-plus) - are crucial. The priority is to quickly identify dangerous causes such as stroke or cardiac arrhythmias. Diagnostic tests should be targeted to avoid overdiagnosis. The treatment depends on the cause and should be based on guidelines.

简介:头晕是一个最常见的,但诊断具有挑战性的主要症状与广泛的原因。它占急诊室和全科门诊所有会诊的2- 8%。极其广泛的鉴别诊断,涵盖了许多医学专业,症状往往是短暂的,患者难以将所经历的症状用语言表达出来,这往往使头晕的评估具有挑战性。有组织的病史和有针对性的临床检查至关重要,特别是关注病程、诱因和动眼肌体征(HINTS-plus)。当务之急是迅速查明中风或心律失常等危险原因。诊断测试应该有针对性,以避免过度诊断。治疗取决于病因,应该以指导方针为基础。
{"title":"[Acute and episodic dizziness - diagnosis and treatment].","authors":"Alexander A Tarnutzer","doi":"10.23785/TU.2025.03.005","DOIUrl":"https://doi.org/10.23785/TU.2025.03.005","url":null,"abstract":"<p><strong>Introduction: </strong>Dizziness is one of the most common, yet diagnostically challenging cardinal symptoms with a wide range of causes. It accounts for 2-8 % of all consultations in both the emergency room and in general practice. The extremely broad differential diagnosis, which covers numerous medical specialties, the often transient nature of the symptoms, and the difficulty for patients to put the experienced symptoms into words, often make the evaluation of dizziness challenging. A structured history and targeted clinical examination - particularly with a focus on duration, triggers and oculomotor signs (HINTS-plus) - are crucial. The priority is to quickly identify dangerous causes such as stroke or cardiac arrhythmias. Diagnostic tests should be targeted to avoid overdiagnosis. The treatment depends on the cause and should be based on guidelines.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"88-93"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epileptic seizures as a key neurological symptom: diagnosis, differential diagnosis and management]. 【癫痫发作作为一种关键的神经系统症状:诊断、鉴别诊断和治疗】。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.002
Silke Biethahn

Introduction: Epileptic seizures rank among the most striking neurological key symptoms and pose a particular diagnostic challenge, especially when occurring for the first time. Differentiating between provoked, unprovoked seizures and epilepsy is essential for making appropriate therapeutic decisions. A thorough medical history, supported by EEG, MRI, and laboratory tests, usually allows for a well-founded classification and helps exclude important differential diagnoses such as syncope or psychogenic non-epileptic seizures. The International League Against Epilepsy (ILAE) classifies seizures based on their origin into focal, generalized, and seizures of unknown onset, which facilitates therapeutic categorization. Acute management is particularly indicated in cases of seizure clusters or status epilepticus. The decision to initiate long-term antiseizure therapy should be made on an individual basis and depends on seizure type, etiology, risk of recurrence, comorbidities, and the patient's individual life circumstances. Patient education is a central aspect of management and should cover trigger factors, therapy adherence, everyday safety risks, and driving eligibility. Early and differentiated diagnostics combined with an individually tailored treatment approach can significantly improve the prognosis - around two-thirds of affected individuals achieve seizure freedom with antiseizure therapy.

引言:癫痫发作是最显著的神经系统关键症状之一,对诊断具有特殊的挑战,特别是首次发生时。区分诱发性、非诱发性发作和癫痫对于作出适当的治疗决定至关重要。在脑电图、MRI和实验室检查的支持下,全面的病史通常允许有充分根据的分类,并有助于排除重要的鉴别诊断,如晕厥或心因性非癫痫发作。国际抗癫痫联盟(ILAE)根据癫痫发作的来源将癫痫发作分为局灶性癫痫发作、全面性癫痫发作和起病原因不明的癫痫发作,这有利于治疗分类。急性管理特别适用于发作集群或癫痫持续状态的病例。开始长期抗癫痫治疗的决定应根据个人情况,并取决于癫痫类型、病因、复发风险、合并症和患者的个人生活情况。患者教育是管理的核心方面,应涵盖触发因素、治疗依从性、日常安全风险和驾驶资格。早期和鉴别诊断结合个体化治疗方法可以显著改善预后——大约三分之二的患者通过抗癫痫治疗实现了癫痫的自由发作。
{"title":"[Epileptic seizures as a key neurological symptom: diagnosis, differential diagnosis and management].","authors":"Silke Biethahn","doi":"10.23785/TU.2025.03.002","DOIUrl":"https://doi.org/10.23785/TU.2025.03.002","url":null,"abstract":"<p><strong>Introduction: </strong>Epileptic seizures rank among the most striking neurological key symptoms and pose a particular diagnostic challenge, especially when occurring for the first time. Differentiating between provoked, unprovoked seizures and epilepsy is essential for making appropriate therapeutic decisions. A thorough medical history, supported by EEG, MRI, and laboratory tests, usually allows for a well-founded classification and helps exclude important differential diagnoses such as syncope or psychogenic non-epileptic seizures. The International League Against Epilepsy (ILAE) classifies seizures based on their origin into focal, generalized, and seizures of unknown onset, which facilitates therapeutic categorization. Acute management is particularly indicated in cases of seizure clusters or status epilepticus. The decision to initiate long-term antiseizure therapy should be made on an individual basis and depends on seizure type, etiology, risk of recurrence, comorbidities, and the patient's individual life circumstances. Patient education is a central aspect of management and should cover trigger factors, therapy adherence, everyday safety risks, and driving eligibility. Early and differentiated diagnostics combined with an individually tailored treatment approach can significantly improve the prognosis - around two-thirds of affected individuals achieve seizure freedom with antiseizure therapy.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"70-75"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Focus on MS - visual loss as a cardinal symptom of multiple sclerosis]. [关注多发性硬化症-视力丧失作为多发性硬化症的主要症状]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.003
Stefanie Müller

Introduction: Visual disturbances are a common presenting symptom of multiple sclerosis (MS), often caused by optic neuritis. This acute inflammation of the optic nerve leads to pain during eye movements, visual impairment and colour vision defects. Optic neuritis can be idiopathic, MS-associated or occur in the context of other diseases such as NMOSD or MOGAD. Diagnosis is based on clinical findings, imaging and visual evoked potentials. Early high-dose corticosteroid treatment can support recovery and improve long-term prognosis.

简介:视觉障碍是多发性硬化症(MS)的常见症状,通常由视神经炎引起。这种视神经的急性炎症会导致眼球运动疼痛、视觉障碍和色觉缺陷。视神经炎可以是特发性的,ms相关的或发生在其他疾病的背景下,如NMOSD或MOGAD。诊断是基于临床表现、影像学和视觉诱发电位。早期大剂量皮质类固醇治疗可支持康复并改善长期预后。
{"title":"[Focus on MS - visual loss as a cardinal symptom of multiple sclerosis].","authors":"Stefanie Müller","doi":"10.23785/TU.2025.03.003","DOIUrl":"https://doi.org/10.23785/TU.2025.03.003","url":null,"abstract":"<p><strong>Introduction: </strong>Visual disturbances are a common presenting symptom of multiple sclerosis (MS), often caused by optic neuritis. This acute inflammation of the optic nerve leads to pain during eye movements, visual impairment and colour vision defects. Optic neuritis can be idiopathic, MS-associated or occur in the context of other diseases such as NMOSD or MOGAD. Diagnosis is based on clinical findings, imaging and visual evoked potentials. Early high-dose corticosteroid treatment can support recovery and improve long-term prognosis.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"76-81"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leitsymptome in der Neurologie – eine Übersicht für die Grundversorgung. 神经病学的基本原理。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.23785/TU.2025.03.001
Andreas R Gantenbein

Introduction:

作品简介:
{"title":"Leitsymptome in der Neurologie – eine Übersicht für die Grundversorgung.","authors":"Andreas R Gantenbein","doi":"10.23785/TU.2025.03.001","DOIUrl":"10.23785/TU.2025.03.001","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 3","pages":"69"},"PeriodicalIF":0.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144555288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Phosphatidyethanol in the diagnosis and treatment of alcohol-related disorders]. [磷脂乙醇在酒精相关疾病诊断和治疗中的应用]。
IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.23785/TU.2025.02.003
Philippe Pfeifer, Panagiota Ntinopoulou, Matthias Bantle, Wolfgang Weinmann

Introduction: The diagnosis and treatment of alcohol use disorders often pose complex questions and challenges for healthcare professionals. In addition to the established indirect biomarkers (e. g. carbohydrate-deficient transferrin [CDT]), clinical research in recent years has produced increasingly valuable findings on the use of direct biomarkers. In this regard, the marker phosphatidyltethanol (PEth), a lipid metabolite that is formed during the breakdown of ethanol, is stored in the erythrocytes, should be emphasized in particular. The advantage of targeted use of PEth in general medical and psychiatric practice to improve diagnostics and therapy has been demonstrated in clinical studies in recent years. Together with the established screening instruments (e. g. AUDIT), PEth can lead to greater validity in the diagnosis of alcohol use disorders. Targeted use of PEth can be used to control treatment goals (e. g. abstinence vs. controlled drinking) and monitor them longitudinally. The determination of PEth generally facilitates and improves communication with patients and can contribute to a destigmatization of the clinical picture, as certain feelings of shame and inhibitions in doctor-patient contact could be diminished.

简介:酒精使用障碍的诊断和治疗往往提出了复杂的问题和卫生保健专业人员的挑战。除了已建立的间接生物标志物(例如:碳水化合物缺乏转铁蛋白[CDT]),近年来的临床研究在使用直接生物标志物方面产生了越来越有价值的发现。在这方面,应该特别强调标记磷脂酰乙醇(PEth),一种在乙醇分解过程中形成的脂质代谢物,储存在红细胞中。近年来的临床研究证明,在普通医学和精神病学实践中有针对性地使用聚醚砜以改善诊断和治疗的优势。连同已建立的筛选工具(例如:审计),PEth可提高酒精使用障碍诊断的有效性。有针对性地使用PEth可用于控制治疗目标(例如:禁欲与控制饮酒),并对其进行纵向监测。确定PEth通常会促进和改善与患者的沟通,并有助于消除临床症状的污名化,因为医患接触中的某些羞耻感和抑制性可以减少。
{"title":"[Phosphatidyethanol in the diagnosis and treatment of alcohol-related disorders].","authors":"Philippe Pfeifer, Panagiota Ntinopoulou, Matthias Bantle, Wolfgang Weinmann","doi":"10.23785/TU.2025.02.003","DOIUrl":"https://doi.org/10.23785/TU.2025.02.003","url":null,"abstract":"<p><strong>Introduction: </strong>The diagnosis and treatment of alcohol use disorders often pose complex questions and challenges for healthcare professionals. In addition to the established indirect biomarkers (e. g. carbohydrate-deficient transferrin [CDT]), clinical research in recent years has produced increasingly valuable findings on the use of direct biomarkers. In this regard, the marker phosphatidyltethanol (PEth), a lipid metabolite that is formed during the breakdown of ethanol, is stored in the erythrocytes, should be emphasized in particular. The advantage of targeted use of PEth in general medical and psychiatric practice to improve diagnostics and therapy has been demonstrated in clinical studies in recent years. Together with the established screening instruments (e. g. AUDIT), PEth can lead to greater validity in the diagnosis of alcohol use disorders. Targeted use of PEth can be used to control treatment goals (e. g. abstinence vs. controlled drinking) and monitor them longitudinally. The determination of PEth generally facilitates and improves communication with patients and can contribute to a destigmatization of the clinical picture, as certain feelings of shame and inhibitions in doctor-patient contact could be diminished.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"82 2","pages":"48-52"},"PeriodicalIF":0.2,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143990952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
THERAPEUTISCHE UMSCHAU
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1